Logo     Print Page  Close Window


SEC Filings


10-Q
FIBROCELL SCIENCE, INC. filed this Form 10-Q on 08/09/2018
Entire Document
 
Fibrocell Science, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)

Note 9. Loss Per Share (continued)

    
Details in the computation of basic and diluted loss per share is as follows:
 
Three months ended June 30,
 
Six months ended  June 30,
($ in thousands except share and per share data)
2018
 
2017
 
2018
 
2017
Loss per share - basic:
 
 
 
 
 
 
 
Net loss
$
(2,894
)
 
$
(14,018
)
 
$
(5,795
)
 
$
(19,025
)
Less: Dividend paid in-kind to preferred stockholders
(83
)
 
(80
)
 
(165
)
 
(100
)
Less: Deemed dividend on preferred stock
(126
)
 
(136
)
 
(247
)
 
(3,870
)
Net loss attributable to common stockholders - basic
$
(3,103
)
 
$
(14,234
)
 
$
(6,207
)
 
$
(22,995
)
 
 
 
 
 
 
 
 
Numerator for basic loss per share
$
(3,103
)
 
$
(14,234
)
 
$
(6,207
)
 
$
(22,995
)
Denominator for basic loss per share
6,376,048

 
2,940,899

 
6,026,454

 
2,940,763

Basic loss per common share
$
(0.49
)
 
$
(4.84
)
 
$
(1.03
)
 
$
(7.82
)
 
 
 
 
 
 
 
 
Loss per share - diluted:
 
 
 
 
 

 
 

Numerator for basic loss per share
$
(3,103
)
 
$
(14,234
)
 
$
(6,207
)
 
$
(22,995
)
Plus: Warrant revaluation income for dilutive warrants

 

 

 

Net loss attributable to common stockholders - diluted
$
(3,103
)
 
$
(14,234
)
 
$
(6,207
)
 
$
(22,995
)
 
 
 
 
 
 
 
 
Denominator for basic loss per share
6,376,048

 
2,940,899

 
6,026,454

 
2,940,763

Adjust: Incremental shares underlying dilutive “in the money” warrants outstanding

 

 

 

Denominator for diluted loss per share
6,376,048

 
2,940,899

 
6,026,454

 
2,940,763

Diluted net loss per common share
$
(0.49
)
 
$
(4.84
)
 
$
(1.03
)
 
$
(7.82
)

The following potentially dilutive securities have been excluded from the computations of diluted weighted-average shares outstanding, as their effect would be anti-dilutive: 
 
Three months ended Junes 30,
 
Six months ended  June 30,
 
2018
 
2017
 
2018
 
2017
“In the money” stock options
36,000

 
47,928

 
36,000

 
39,193

“Out of the money” stock options
263,467

 
143,587

 
263,467

 
142,013

“In the money” warrants
1,528,668

 
9,286

 
1,528,668

 
9,286

“Out of the money” warrants
4,903,736

 
2,073,024

 
4,903,736

 
2,073,024

Shares underlying convertible notes
1,056,068

 
1,058,004

 
1,056,068

 
1,058,004

Shares underlying convertible accrued interest on convertible notes
79,120

 
34,855

 
79,120

 
34,855

Shares underlying convertible preferred stock
720,000

 
696,000

 
720,000

 
696,000


25